Details of the Drug

General Information of Drug (ID: DMXA9KU)

• Drug Name: Catumaxomab

Indication

Disease Entry	ICD 11	Status	REF
Malignant pleural effusion	2D72	Approved	[1]
Ovarian cancer	2C73	Phase 2	[2]

• Affected Organisms: Humans
• ATC Code:
  L01FX03: Catumaxomab
  L01FX: Other monoclonal antibodies and antibody drug conjugates
  L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
  L01: ANTINEOPLASTIC AGENTS
  L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
• Drug Type: Monoclonal antibody
• Cross-matching ID:
  UNII: M2HPV837HO
  DrugBank ID: DB06607
  TTD ID: D0O5ER
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7385).
• [2] ClinicalTrials.gov (NCT00377429) Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy. U.S. National Institutes of Health.